R17934-NSC238159: a new antitumor drug--II. Effect on mitotic cycle of L1210 leukemia cells in vivo and synergism with cytosine arabinoside (NSC63878)
- PMID: 1220976
- DOI: 10.1016/0014-2964(75)90093-6
R17934-NSC238159: a new antitumor drug--II. Effect on mitotic cycle of L1210 leukemia cells in vivo and synergism with cytosine arabinoside (NSC63878)
Similar articles
-
R17934-NSC 238159: a new antitumor drug--I. Effect on experimental tumors and factors influencing effectiveness.Eur J Cancer (1965). 1975 Sep;11(9):599-607. doi: 10.1016/0014-2964(75)90092-4. Eur J Cancer (1965). 1975. PMID: 1220975 No abstract available.
-
Response of L1210 to combinations of cytosine arabinoside and VM-26 or VP16-213.Eur J Cancer (1965). 1975 Sep;11(9):639-47. doi: 10.1016/0014-2964(75)90099-7. Eur J Cancer (1965). 1975. PMID: 1220978 No abstract available.
-
Influence of mitotic cycle inhibitors on the antileukemic activity of cytosine arabinoside (NSC-63878) in mice bearing leukemia L1210.Cancer Chemother Rep. 1971 Dec;55(5):547-55. Cancer Chemother Rep. 1971. PMID: 5159846 No abstract available.
-
The chemotherapy of human and animal acute leukemia.Cancer Chemother Rep. 1971 Nov;55(4):309-505. Cancer Chemother Rep. 1971. PMID: 4945857 Review. No abstract available.
-
[The mechanism of synergistic interaction between etoposide and cytarabine].Yakugaku Zasshi. 2002 Jul;122(7):471-80. doi: 10.1248/yakushi.122.471. Yakugaku Zasshi. 2002. PMID: 12136643 Review. Japanese.
Cited by
-
Differential binding of methyl benzimidazol-2-yl carbamate to fungal tubulin as a mechanism of resistance to this antimitotic agent in mutant strains of Aspergillus nidulans.J Cell Biol. 1977 Jan;72(1):174-93. doi: 10.1083/jcb.72.1.174. J Cell Biol. 1977. PMID: 12184 Free PMC article.
-
Ineffectiveness of inicarone, a fibrinolytic agent, alone or in combination with chemotherapeutic agents on spontaneously metastasizing murine tumours.Clin Exp Metastasis. 1983 Oct-Dec;1(4):349-57. doi: 10.1007/BF00121197. Clin Exp Metastasis. 1983. PMID: 6546206
-
Preclinical antitumor activity and pharmacokinetics of methyl-2-benzimidazolecarbamate (FB642).Invest New Drugs. 2002 Aug;20(3):261-70. doi: 10.1023/a:1016253716438. Invest New Drugs. 2002. PMID: 12201489